| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |